Stockreport

TherapeuticsMD Announces Second Quarter 2024 Financial Results

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com
PDF BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, t [Read more]